BioSpace News Archive

Press Releases

Gilead and Tubulis Enter Into Exclusive Option and License Agreement to Develop ADC Candidate for Select Solid Tumor Target

December 3, 2024
·
5 min read
Press Releases

Rakovina Therapeutics Announces Presentation at the 13th Annual Tumour Models London Summit

December 3, 2024
·
4 min read
Press Releases

Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies

December 3, 2024
·
8 min read
Press Releases

Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology

December 3, 2024
·
4 min read
Press Releases

NovelMed Receives FDA IND Approval for NM8074 (Ruxoprubart), the First Anti-Bb Alternative Pathway Blocker for Treating Primary Immunoglobulin A Nephropathy (IgAN): A Renal Disorder

December 3, 2024
·
5 min read
Press Releases

SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver

December 3, 2024
·
2 min read
Press Releases

Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference

December 3, 2024
·
1 min read
Press Releases

UPSHER-SMITH TO FEATURE MULTIPLE PRESENTATIONS AT THE AMERICAN EPILEPSY SOCIETY (AES) 2024 ANNUAL MEETING

December 3, 2024
·
14 min read
Press Releases

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - December 2, 2024

December 3, 2024
·
1 min read
Press Releases

MAPLIGHT THERAPEUTICS ANNOUNCES RESULTS FROM PHASE 1 TRIAL OF NOVEL M1/M4 MUSCARINIC AGONIST IN DEVELOPMENT FOR TREATMENT OF SCHIZOPHRENIA AND ALZHEIMER’S DISEASE PSYCHOSIS

December 3, 2024
·
4 min read